Phase 2
Completed N=24
Treatment of Anxiety and Anorexia Nervosa in Adolescents
Source: ClinicalTrials.gov NCT01933243 ↗Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Apr 2018
Primary outcomePrimary: Medication Side Effects Score — 9.5; 6.2; 6.4; 4.1 Score on a scale
Summary
Adolescents with anorexia nervosa frequently have associated anxiety, and standard medications used for anxiety are unhelpful when patients are malnourished. This is a 12 week trial examining the safety, tolerability, and effectiveness of fish oil nutritional supplements for anxiety in adolescents with anorexia nervosa.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Medication Side Effects Score |
9.5; 6.2; 6.4; 4.1 | — |
| SECONDARY Beck Anxiety Inventory-Trait (BAIT) |
26.4; 19.3; 21.9; 11; 14.9; 6.5 | — |
Eligibility Criteria
Inclusion Criteria
Females admitted to Nationwide Children's Hospital Eating Disorder Partial Hospitalization Program
Exclusion Criteria
- Inability to take pills
- Co-morbid medical conditions affecting appetite and weight (e.g., inflammatory bowel disease, cancer, cystic fibrosis)
- Co-morbid psychiatric conditions affecting appetite and weight (e.g., bipolar disorder, substance abuse)
- Currently taking fish oil supplements
- Inability to participate in study for 12 consecutive weeks.
Data sourced from ClinicalTrials.gov (NCT01933243). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.